Metabolic syndrome: A patient-related prognostic factor for cancer?

J Cancer Res Ther. 2022 Jul-Sep;18(4):1210-1211. doi: 10.4103/jcrt.JCRT_323_19.

Authors

Priscila da Silva Mendonça¹, Ana Patrícia Nogueira Aguiar², Ronald Feitosa Pinheiro², Sílvia Maria Meira Magalhães²

Affiliations

¹ Cancer Cytogenomic Laboratory, Federal University of Ceará: Brazilian Company of Hospital Services, University Hospital Walter Cantidio, Fortaleza, Brazil.
² Department of Clinical Medicine, Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil.

PMID: 36149193
DOI: 10.4103/jcrt.JCRT_323_19

No abstract available

Publication types

Letter
Comment

MeSH terms

Disease-Free Survival
Humans
Metabolic Syndrome* / complications
Metabolic Syndrome* / diagnosis
Neoplasms* / complications
Neoplasms* / diagnosis
Prognosis